Related Experiment Video
Updated: Apr 7, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Effects of Baduanjin on response inhibition in children with attention-deficit/hyperactivity disorder: A randomized
Zeping Zhang1, Yu Zhang2, Jintao Li3
1School of Police Law Enforcement Abilities Training, People's Public Security University of China, Beijing 100038, China.
Insights
Twelve weeks of Baduanjin exercise improved response inhibition in children with attention-deficit/hyperactivity disorder (ADHD). Behavioral improvements were noted, but neural-level changes require further study.
Area of Science:
- Neuroscience
- Child Psychology
- Integrative Medicine
Background:
- Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder characterized by inattention and hyperactivity.
- Deficits in response inhibition are a core symptom of ADHD, impacting behavior and cognitive function.
- Non-pharmacological interventions are sought to complement traditional ADHD treatments.
Purpose of the Study:
- To investigate the efficacy of a 12-week Baduanjin intervention on response inhibition in children with ADHD.
- To assess the impact of Baduanjin on electrophysiological activity during a Go/No-Go task.
- To evaluate behavioral changes using parent-reported ADHD symptom scales.
Main Methods:
- A randomized controlled trial (RCT) involving 90 children diagnosed with ADHD.
- Participants were assigned to Baduanjin, regular physical activity, or waitlist control groups for 12 weeks.
- Behavioral data (Go/No-Go task performance, SNAP-IV scores) and event-related potentials (ERPs) were collected pre- and post-intervention.
Main Results:
- The Baduanjin group demonstrated a significant reduction in No-Go error rates on the Go/No-Go task.
- Parent-reported ADHD symptom scores (SNAP-IV) decreased in both Baduanjin and regular physical activity groups.
- No significant changes in event-related potentials (N2/P3 amplitudes) were observed between groups.
Conclusions:
- Baduanjin exercise shows potential as an intervention to improve behavioral response inhibition in children with ADHD.
- Further research is needed to elucidate the neural mechanisms underlying these behavioral improvements.
- The findings suggest Baduanjin may be a valuable complementary therapy for ADHD management.
Objective:
This study aimed to examine the effects of a 12-week Baduanjin intervention on response inhibition and electrophysiological activity in children with attention-deficit/hyperactivity disorder (ADHD).
Methods:
In this randomized controlled trial (RCT), 90 children with ADHD were randomly assigned to a Baduanjin, regular physical activity, or waitlist control group for 12 weeks. Behavioral performance and event-related potentials (ERP) during a Go/No-Go task were measured pre- and post-intervention. Parents completed the Swanson, Nolan, and Pelham IV scale (SNAP-IV) at both time points.
Results:
After 12 weeks, SNAP-IV scores decreased in the Baduanjin and regular physical activity groups, with no significant change in the control group. In the Go/No-Go task, the Baduanjin group showed a reduction in No-Go error rates, the regular physical activity group showed no change, and the control group showed a trend toward increased errors. Neurophysiologically, only the N2/P3 components showed larger amplitudes in the No-Go condition compared to Go, with no other significant differences observed.
Conclusion:
Preliminary evidence suggests that Baduanjin has the potential to improve response inhibition in children with ADHD; however, evidence for improvements at the neural level requires further investigation.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018